A previous article reported that fibroblasts with somatic copy number alterations in the TME play synergetic roles in tumor development through complex interactions with cancer cells, and RCN3 is identified as a fibroblast-specific biomarker of poorer prognosis of colorectal cancer (CRC) (21). The gene discussed is RCN3; the disease is cancer.